CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 1)

Average Co-Inventor Count = 10.8

ph-index = 5

Forward Citations = 124(Granted Patents)

Location History:

Ibaraki, JP (1994 - 2010)
Tsukuba, JP (2008 - 2012)
Tokyo, JP (2013)

Company Filing History:

9 out of 677

Eisai Company, Limited

patents

8 out of 527

Eisai R&d Management Co., Ltd.

patents

Years Active: 1994-2013

Loading Chart...

17 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 8436009 - Prodrug of triazolone compound (2013-05-07),

2. 8124780 - Benzimidazole compound (2012-02-28),

3. 7816405 - Calcium bis [(2S)-3-[3-[(2S)-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl ]-2-isopropoxypropionate] and intermediate thereof (2010-10-19),

4. 7687664 - Carboxylic acid derivative, a salt thereof or an ester of them, and medicament comprising it (2010-03-30),

5. 7544835 - Carboxylic acid derivative and salt thereof (2009-06-09),

6. 7476688 - Cyclic amidine derivatives (2009-01-13),

7. 7425634 - Benzimidazole compound (2008-09-16),

8. 7371777 - Cyclic compound and PPAR agonist (2008-05-13),

9. 7304083 - 2-iminoimidazole derivatives (2) (2007-12-04),

10. 7253178 - Carboxylic acids (2007-08-07),

11. 7244861 - Benzene compound and salt thereof (2007-07-17),

12. 7244730 - 2-iminopyrrolidine derivatives (2007-07-17),

13. 6884821 - Carboxylic acid derivatives and drugs containing the same (2005-04-26),

14. 5635519 - Benzothiazole compounds which are substituted by pyridymethyl (1997-06-03),

15. 5420144 - Pyridyl substituted benzothiazole compounds which have useful (1995-05-30),

Title: The Innovations of Masanobu Shinoda: A Look at His Contributions to Pharmacology

Introduction

Masanobu Shinoda, an esteemed inventor based in Ibaraki, Japan, has made significant contributions to the field of pharmacology through his innovative inventions. With a total of 17 patents, he has focused on developing compounds that address various medical conditions, particularly those related to blood coagulation and gastric acid secretion.

Latest Patents

Among his latest inventions is the "Prodrug of Triazolone Compound," which allows for effective oral administration of a compound with potent inhibitory effects against blood coagulation factor VIIa. This compound plays a crucial role in therapeutic applications targeted at diseases caused by thrombus formation. Another notable patent is for a "Benzimidazole Compound," recognized for its therapeutic and prophylactic applications in managing acid-related diseases. This compound exhibits an excellent inhibitory effect on gastric acid secretion and maintains a stable intragastric pH, offering enhanced safety and physicochemical stability.

Career Highlights

Throughout his career, Masanobu Shinoda has worked with prominent companies, including Eisai Company, Limited and Eisai R&D Management Co., Ltd. His work in these organizations has allowed him to further explore innovative pharmacological solutions and contribute to advancements in medical treatments.

Collaborations

Shinoda has collaborated with notable professionals in the field, including Fumiyoshi Matsuura and Richard S. Clark. These collaborations have fostered a dynamic environment for research and development, enabling Shinoda to enhance his inventions and extend their applications in healthcare.

Conclusion

Masanobu Shinoda continues to be an influential figure in the realm of pharmaceutical innovations. With his impressive portfolio of patents and collaborative efforts, he is well-positioned to impact the medical community significantly. His work not only showcases his inventive spirit but also highlights the importance of continuous research in addressing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.